A20 reduces lipid storage and inflammation in hypertrophic adipocytes via p38 and Akt signaling

作者：Ai, Luoyan; Wang, Xiaohan; Chen, Zhiwei; Lin, Qing; Su, Dazhi; Xu, Qingqing; Wu, Changwei; Jiang, Xiaoke; Xu, Antao; Fan, Zhuping^*

来源：Molecular and Cellular Biochemistry, 2016, 420(1-2): 73-83.

DOI：10.1007/s11010-016-2768-0

• A20
• Obesity
• Lipogenesis
• Inflammation
• 3T3-L1

Adipose tissue plays a vital role in the development of obesity and related disorders. Our previous study showed that A20, an ubiquitin-editing enzyme with anti-inflammation function, attenuated free fatty acids (FFAs)-induced lipid accumulation in nonalcoholic steatohepatitis. Here, we investigated A20 expression in adipose tissue of obese individuals and its effects on 3T3-L1 lipogenesis as well as the likely mechanisms underlying this process. By re-annotation of raw microarray data downloaded from Gene Expression Omnibus, we found that obese individuals showed significantly higher A20 mRNA levels in adipocytes. In vitro, A20 inhibited MCP-1 and IL-6 secretion in adipocytes. Forced expression of A20 resulted in decreased expression of key markers of lipogenesis and adipogenesis, such as sterol regulatory element binding protein 1c (SREBP-1c) and adipogenesis (aP2), leading to less lipids accumulation in differentiated 3T3-L1 cells. This process was concomitant with attenuated activation of p38 and Akt signaling. Our results suggest that A20 may have therapeutic potential for obesity and related diseases. The mechanisms involved the suppression of lipid storage and inflammation in adipocytes.

• 出版日期2016-9
• 单位上海交通大学